Blood pressure in diabetic nephropathy--current controversies
Related Experiment Video
Updated: Oct 8, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
1Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany. Prof.E.Ritz@T-online.de
Insights
Hypertension is a key factor in diabetic nephropathy, with early and aggressive blood pressure management crucial for slowing disease progression. Monitoring proteinuria and adjusting ACE inhibitor doses are also vital for optimal patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Diabetic nephropathy frequently presents with hypertension, a condition potentially influenced by genetic factors.
- Hyperglycemia may trigger local renin-angiotensin system activation within the kidneys.
- Antihypertensive therapies are known to slow diabetic nephropathy progression.
Purpose of the Study:
- To review the role of hypertension in diabetic nephropathy.
- To emphasize the importance of early and intensive blood pressure control.
- To highlight the significance of proteinuria monitoring and ACE inhibitor management.
Main Methods:
- Literature review of recent studies on hypertension and diabetic nephropathy.
- Analysis of evidence supporting early and stringent blood pressure targets.
- Discussion of the impact of hyperglycemia on intrarenal renin-angiotensin system.
- Evaluation of proteinuria as a therapeutic target.
Main Results:
- Hypertension is an early and consistent feature of diabetic nephropathy.
- Genetic predisposition to hypertension is a significant risk factor.
- Early and aggressive antihypertensive treatment is increasingly recommended.
- Local renin system activation in the kidney due to hyperglycemia is suggested.
- Proteinuria reduction is a key treatment goal alongside blood pressure control.
Conclusions:
- Aggressive management of hypertension, including very early treatment and low blood pressure targets, is essential in diabetic nephropathy.
- Monitoring and reducing proteinuria are critical, guiding ACE inhibitor therapy.
- Integrated management of blood pressure and proteinuria is key to slowing disease progression.
Abstract:
Hypertension has been recognized as an early and constant feature of diabetic nephropathy, but recent studies also suggest that a genetic predisposition to hypertension is an important risk factor for diabetic nephropathy. Antihypertensive treatment attenuates progression in diabetic nephropathy, but there is increasing evidence that very early treatment and very low target blood pressures should be implemented. There is also evidence for local activation of the renin system in the kidney as a result of hyperglycaemia. Apart from blood pressure, proteinuria should be monitored and dosing of ACE inhibitors should be guided, also by reduction of protein excretion.
Related Concept Videos
Diabetic Nephropathy
Hypertension and Regulation of Blood Pressure
Diabetic Retinopathy
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Antihypertensive Drugs: Action of Diuretics
Hypertension I: Introduction